Skip to contentHERSHBERG ROBERT — NanoString Technologies Inc insider: 179 transactions · InsiderLensHERSHBERG ROBERT
- President and CEO at HilleVax, Inc. · on record since Apr 28, 2022
- Director at RECURSION PHARMACEUTICALS, INC. · on record since Apr 22, 2021
- Director at AtaiBeckley Inc. · on record since Jun 8, 2026
- Director at NanoString Technologies Inc · on record since Mar 3, 2015
- Director at ADAPTEC INC · on record since Jun 26, 2019
- Director at FATE THERAPEUTICS INC · on record since May 5, 2020
- Director at ARS Pharmaceuticals, Inc. · on record since Dec 7, 2020
- Director at HilleVax, Inc. · on record since Apr 28, 2022
- Director at DENDREON CORP · on record since Dec 15, 2005
- Chief Medical Officer at DENDREON CORP · on record since Dec 15, 2005
Insider trading activity of HERSHBERG ROBERT
- Transactions on record
- 179
- since Dec 22, 2003
- Open-market buys
- 0
- Open-market sells
- 57
- $3.9M
- Companies traded
- 8
- last filing Jun 22, 2026
Figures computed from official regulatory filings — methodology.
Companies where HERSHBERG ROBERT has traded
- RECURSION PHARMACEUTICALS, INC.20 tx · Jun 22, 2026
- AtaiBeckley Inc.5 tx · Jun 8, 2026
- ADAPTEC INC63 tx · $2.7M · Mar 6, 2026
- HilleVax, Inc.8 tx · $221.7K · Sep 17, 2025
- FATE THERAPEUTICS INC8 tx · $15.3K · Jun 7, 2023
- ARS Pharmaceuticals, Inc.3 tx · Jun 13, 2022
- NanoString Technologies Inc66 tx · $1.4M · Apr 18, 2022
- DENDREON CORP6 tx · $77.6K · Feb 14, 2006
Track record of HERSHBERG ROBERT
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of HERSHBERG ROBERT
Co-insiders of HERSHBERG ROBERT
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
Adawi KamalFATE THERAPEUTICS INC
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 22, 2026 | Award | 88,424 | 0.00 USD | — | SEC |
| Jun 8, 2026 | AwardD | 121,968 | 0.00 USD | $0 | SEC |
| Mar 6, 2026 | Award | 15,625 | 0.00 USD | $0 | SEC |
| Dec 12, 2025 | Sell | -22,968 | 16.00 USD | $367.5K | SEC |
| Nov 6, 2025 | AwardD | 456,011 | 0.00 USD | $0 | SEC |
| Nov 6, 2025 | AwardD | 103,000 | 0.00 USD | $0 | SEC |
| Nov 6, 2025 | AwardD | 97,716 | 0.00 USD | $0 | SEC |
| Nov 6, 2025 | AwardD | 62,394 | 0.00 USD | $0 | SEC |
| Sep 17, 2025 | Other | -1,101,498 | — | — | SEC |
| Jun 23, 2025 | AwardD | 44,031 | 0.00 USD | $0 | SEC |
| Jun 23, 2025 | Award | 22,016 | 0.00 USD | $0 | SEC |
| Mar 12, 2025 | Sell | -53,000 | 7.59 USD | $402.3K | SEC |
| Mar 6, 2025 | AwardD | 23,726 | 0.00 USD | $0 | SEC |
| Mar 6, 2025 | Award | 15,394 | 0.00 USD | $0 | SEC |
| Feb 12, 2025 | Sell | -14,634 | 1.89 USD | $27.7K | SEC |
| Feb 12, 2025 | Sell | -11,901 | 1.76 USD | $20.9K | SEC |
| Jun 5, 2024 | Award | 13,097 | 0.00 USD | $0 | SEC |
| Jun 5, 2024 | AwardD | 26,193 | 0.00 USD | $0 | SEC |
| Mar 6, 2024 | Award | 31,328 | 0.00 USD | $0 | SEC |
| Mar 6, 2024 | AwardD | 48,044 | 0.00 USD | $0 | SEC |
| Feb 12, 2024 | Sell | -11,597 | 14.93 USD | $173.1K | SEC |
| Feb 12, 2024 | Award | 174,202 | 0.00 USD | $0 | SEC |
| Feb 12, 2024 | AwardD | 226,885 | 0.00 USD | $0 | SEC |
| Jun 21, 2023 | AwardD | 25,224 | 0.00 USD | $0 | SEC |
| Jun 21, 2023 | Award | 12,612 | 0.00 USD | $0 | SEC |